We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“In too many cases, there is no generic competition for these costly branded drugs even after they have lost their exclusivity protections,” said FDA Commissioner Scott Gottlieb. Read More
The complaint alleges that Westminster knew there were problems with the drugs for months but didn’t recall them until after the FDA forced its hand. Read More
The complaint said the device’s bullet tip fell off during a surgical procedure and had to be removed from the patient through medical intervention. Read More
But the New Jersey court disagreed, ruling that consolidating the suits in the Garden State — which has stronger protections for drugmakers who use FDA-approved labeling — was proper because that’s where the drugmaker was headquartered at the time. Read More